Jasper Therapeutics Inc

JSPR

Equity

ISIN null / Valor 131966862

NASDAQ (2026-03-27)

USD 1.05-5.41%

Jasper Therapeutics Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Jasper Therapeutics Inc. is a biotechnology company specializing in the development of targeted therapies for chronic diseases by focusing on mast cells and stem cells. The company's primary investigational drug, briquilimab, is being evaluated for its potential to treat a range of conditions, including chronic urticaria and lower to intermediate risk myelodysplastic syndromes (MDS). Additionally, briquilimab is being studied as a conditioning agent for stem cell transplants in patients with rare diseases such as sickle cell disease (SCD), Fanconi anemia (FA), and severe combined immunodeficiency (SCID). Jasper Therapeutics aims to advance innovative treatments that address significant unmet medical needs in these areas.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-78.3%1Y

-94.4%3Y

-98.9%5Y

Performance

112%1Y

107%3Y

133%5Y

Volatility

29 M

Market cap (USD)

526,938

Daily traded volume (Shares)

22.12 / 20.9

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

4.00

Sabrina von Arx

Switzerland, 27 Mar 2025

Wachstumspotential

EQUITIES OF THE SAME SECTOR

Investor AB

Investor AB Valor: 111465893

Annual Return

-50%0%+50%

Risk level

110

-0.17%SEK 342.90

Swedbank AB

Swedbank AB Valor: 212308

Annual Return

-50%0%+50%

Risk level

110

1.22%SEK 307.90

OEKOWORLD AG

OEKOWORLD AG Valor: 1472233

Annual Return

-50%0%+50%

Risk level

110

-1.90%EUR 25.80

Intercontinental Exchange Inc

Intercontinental Exchange Inc Valor: 22339711

Annual Return

-50%0%+50%

Risk level

110

-2.11%USD 152.67

Protector Forsikring Asa

Protector Forsikring Asa Valor: 2213231

Annual Return

-50%0%+50%

Risk level

110

-0.97%NOK 459.00

Credit Acceptance Corp

Credit Acceptance Corp Valor: 922610

Annual Return

-50%0%+50%

Risk level

110

-5.27%USD 419.49

First Interstate Bancsystem Inc

First Interstate Bancsystem Inc Valor: 11165896

Annual Return

-50%0%+50%

Risk level

110

-2.06%USD 32.81

Affiliated Managers Group Inc

Affiliated Managers Group Inc Valor: 791448

Annual Return

-50%0%+50%

Risk level

110

-2.66%USD 268.98

Spire Inc

Spire Inc Valor: 32158647

Annual Return

-50%0%+50%

Risk level

110

-0.45%USD 90.68

Avance Gas Holding Ltd

Avance Gas Holding Ltd Valor: 22521814

Annual Return

-50%0%+50%

Risk level

110

77.78%NOK 0.24

Logos provided by Clearbit

Jasper Therapeutics Inc

JSPR

ISIN null / Valor 131966862

Jasper Therapeutics Inc UMushroom community rating:

Sabrina von Arx

Jasper Therapeutics Inc
UMushroom community rating: